BRT APARTMENTS CORP (BRT)

US0556453035 - REIT

18.01  +0.37 (+2.1%)

After market: 18.01 0 (0%)

Fundamental Rating

3

BRT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. While BRT seems to be doing ok healthwise, there are quite some concerns on its profitability. BRT is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

BRT had negative earnings in the past year.
In the past year BRT had a positive cash flow from operations.
BRT had positive earnings in 4 of the past 5 years.
In multiple years BRT reported negative operating cash flow during the last 5 years.

1.2 Ratios

BRT's Return On Assets of -1.73% is on the low side compared to the rest of the industry. BRT is outperformed by 90.00% of its industry peers.
BRT's Return On Equity of -5.91% is on the low side compared to the rest of the industry. BRT is outperformed by 85.00% of its industry peers.
BRT has a worse Return On Invested Capital (1.53%) than 65.00% of its industry peers.
Industry RankSector Rank
ROA -1.73%
ROE -5.91%
ROIC 1.53%
ROA(3y)4.57%
ROA(5y)1.7%
ROE(3y)12.01%
ROE(5y)5.06%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of BRT has declined.
Looking at the Operating Margin, with a value of 11.35%, BRT is doing worse than 75.00% of the companies in the same industry.
BRT's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 54.92%, BRT is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BRT has remained more or less at the same level.
Industry RankSector Rank
OM 11.35%
PM (TTM) N/A
GM 54.92%
OM growth 3YN/A
OM growth 5Y-6.78%
PM growth 3YN/A
PM growth 5Y-26.96%
GM growth 3Y-0.33%
GM growth 5Y1.31%

4

2. Health

2.1 Basic Checks

BRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BRT has less shares outstanding
Compared to 5 years ago, BRT has more shares outstanding
The debt/assets ratio for BRT is higher compared to a year ago.

2.2 Solvency

BRT has an Altman-Z score of 0.55. This is a bad value and indicates that BRT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.55, BRT is doing worse than 70.00% of the companies in the same industry.
The Debt to FCF ratio of BRT is 31.49, which is on the high side as it means it would take BRT, 31.49 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BRT (31.49) is better than 75.00% of its industry peers.
BRT has a Debt/Equity ratio of 2.31. This is a high value indicating a heavy dependency on external financing.
BRT has a Debt to Equity ratio of 2.31. This is in the lower half of the industry: BRT underperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF 31.49
Altman-Z 0.55
ROIC/WACC0.26
WACC5.93%

2.3 Liquidity

BRT has a Current Ratio of 1.94. This is a normal value and indicates that BRT is financially healthy and should not expect problems in meeting its short term obligations.
BRT's Current ratio of 1.94 is amongst the best of the industry. BRT outperforms 90.00% of its industry peers.
BRT has a Quick Ratio of 1.94. This is a normal value and indicates that BRT is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.94, BRT belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94

3

3. Growth

3.1 Past

The earnings per share for BRT have decreased strongly by -1100.00% in the last year.
Measured over the past years, BRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.10% on average per year.
The Revenue has grown by 27.74% in the past year. This is a very strong growth!
Measured over the past years, BRT shows a decrease in Revenue. The Revenue has been decreasing by -4.78% on average per year.
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5Y-33.1%
EPS Q2Q%-50%
Revenue 1Y (TTM)27.74%
Revenue growth 3Y49.35%
Revenue growth 5Y-4.78%
Sales Q2Q%2.28%

3.2 Future

BRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -76.86% yearly.
Based on estimates for the next years, BRT will show a small growth in Revenue. The Revenue will grow by 2.62% on average per year.
EPS Next Y-462.48%
EPS Next 2Y-129.2%
EPS Next 3Y-76.86%
EPS Next 5YN/A
Revenue Next Year1.87%
Revenue Next 2Y3.25%
Revenue Next 3Y4.79%
Revenue Next 5Y2.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRT. In the last year negative earnings were reported.
Also next year BRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

BRT's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRT indicates a rather cheap valuation: BRT is cheaper than 95.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.02
EV/EBITDA 19.81

4.3 Compensation for Growth

A cheap valuation may be justified as BRT's earnings are expected to decrease with -76.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-129.2%
EPS Next 3Y-76.86%

6

5. Dividend

5.1 Amount

BRT has a Yearly Dividend Yield of 5.67%, which is a nice return.
Compared to an average industry Dividend Yield of 4.12, BRT pays a better dividend. On top of this BRT pays more dividend than 90.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, BRT pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.67%

5.2 History

The dividend of BRT has a limited annual growth rate of 5.54%.
BRT has paid a dividend for at least 10 years, which is a reliable track record.
BRT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)5.54%
Div Incr Years6
Div Non Decr Years6

5.3 Sustainability

BRT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-150.11%
EPS Next 2Y-129.2%
EPS Next 3Y-76.86%

BRT APARTMENTS CORP

NYSE:BRT (1/3/2025, 8:23:27 PM)

After market: 18.01 0 (0%)

18.01

+0.37 (+2.1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners47.31%
Inst Owner Change4.28%
Ins Owners22.46%
Ins Owner Change-0.69%
Market Cap338.77M
Analysts80
Price Target22.44 (24.6%)
Short Float %1.46%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield 5.67%
Dividend Growth(5Y)5.54%
DP-150.11%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.65%
Min EPS beat(2)19.55%
Max EPS beat(2)25.74%
EPS beat(4)2
Avg EPS beat(4)4.04%
Min EPS beat(4)-20.23%
Max EPS beat(4)25.74%
EPS beat(8)5
Avg EPS beat(8)8.59%
EPS beat(12)9
Avg EPS beat(12)178.79%
EPS beat(16)12
Avg EPS beat(16)122.8%
Revenue beat(2)2
Avg Revenue beat(2)0.77%
Min Revenue beat(2)0.1%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.77%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)7
Avg Revenue beat(12)6.31%
Revenue beat(16)9
Avg Revenue beat(16)5.53%
PT rev (1m)1.54%
PT rev (3m)1.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.7%
EPS NY rev (1m)1.68%
EPS NY rev (3m)3.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.43%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.86
P/FCF 22.02
P/OCF 15.02
P/B 1.61
P/tB 1.61
EV/EBITDA 19.81
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)0.82
FCFY4.54%
OCF(TTM)1.2
OCFY6.66%
SpS6.3
BVpS11.16
TBVpS11.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.73%
ROE -5.91%
ROCE 1.94%
ROIC 1.53%
ROICexc 1.64%
ROICexgc 1.68%
OM 11.35%
PM (TTM) N/A
GM 54.92%
FCFM 12.97%
ROA(3y)4.57%
ROA(5y)1.7%
ROE(3y)12.01%
ROE(5y)5.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.08%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.85%
OM growth 3YN/A
OM growth 5Y-6.78%
PM growth 3YN/A
PM growth 5Y-26.96%
GM growth 3Y-0.33%
GM growth 5Y1.31%
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF 31.49
Debt/EBITDA 12.34
Cap/Depr 27.83%
Cap/Sales 6.05%
Interest Coverage 0.65
Cash Conversion 57.48%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z 0.55
F-Score5
WACC5.93%
ROIC/WACC0.26
Cap/Depr(3y)25.19%
Cap/Depr(5y)23.09%
Cap/Sales(3y)7.77%
Cap/Sales(5y)6.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5Y-33.1%
EPS Q2Q%-50%
EPS Next Y-462.48%
EPS Next 2Y-129.2%
EPS Next 3Y-76.86%
EPS Next 5YN/A
Revenue 1Y (TTM)27.74%
Revenue growth 3Y49.35%
Revenue growth 5Y-4.78%
Sales Q2Q%2.28%
Revenue Next Year1.87%
Revenue Next 2Y3.25%
Revenue Next 3Y4.79%
Revenue Next 5Y2.62%
EBIT growth 1Y162.89%
EBIT growth 3YN/A
EBIT growth 5Y-11.24%
EBIT Next Year319.08%
EBIT Next 3Y66.68%
EBIT Next 5YN/A
FCF growth 1Y343.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.13%
OCF growth 3YN/A
OCF growth 5Y-12.67%